The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner

Immunity

Volumn 32, Issue 5, 2010, Pages 628-641

  Carotta, Sebastian ^a   Dakic, Aleksandar ^a   D'Amico, Angela ^a   Pang, Swee Heng Milon ^a,b   Greig, Kylie T ^a,b   Nutt, Stephen L ^a   Wu, Li ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cellimmuno; Molimmuno

Indexed keywords

FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TRANSCRIPTION FACTOR PU 1;

ADULT ANIMAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LINE; CELL MATURATION; CONCENTRATION PROCESS; CONTROLLED STUDY; DENDRITIC CELL; DEVELOPMENTAL STAGE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS;

EID: 77953282048     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2010.05.005     Document Type: Article

References (53)

1. Adolfsson J., Månsson R., Buza-Vidas N., Hultquist A., Liuba K., Jensen C.T., Bryder D., Yang L., Borge O.J., Thoren L.A., et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 2005, 121:295-306.
2. Anderson K.L., Perkin H., Surh C.D., Venturini S., Maki R.A., Torbett B.E. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J. Immunol. 2000, 164:1855-1861.
3. Anderson M.K., Weiss A.H., Hernandez-Hoyos G., Dionne C.J., Rothenberg E.V. Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage. Immunity 2002, 16:285-296.
4. Back J., Allman D., Chan S., Kastner P. Visualizing PU.1 activity during hematopoiesis. Exp. Hematol. 2005, 33:395-402.
5. Bakri Y., Sarrazin S., Mayer U.P., Tillmanns S., Nerlov C., Boned A., Sieweke M.H. Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate. Blood 2005, 105:2707-2716.
6. Boyer L.A., Plath K., Zeitlinger J., Brambrink T., Medeiros L.A., Lee T.I., Levine S.S., Wernig M., Tajonar A., Ray M.K., et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006, 441:349-353.
7. Carotta S., Brady J., Wu L., Nutt S.L. Transient Notch signaling induces NK cell potential in Pax5-deficient pro-B cells. Eur. J. Immunol. 2006, 36:3294-3304.
8. D'Amico A., Wu L. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J. Exp. Med. 2003, 198:293-303.
9. Dahl R., Walsh J.C., Lancki D., Laslo P., Iyer S.R., Singh H., Simon M.C. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor. Nat. Immunol. 2003, 4:1029-1036.
10. Dakic A., Metcalf D., Di Rago L., Mifsud S., Wu L., Nutt S.L. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J. Exp. Med. 2005, 201:1487-1502.
11. Dakic A., Wu L., Nutt S.L. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?. Trends Immunol. 2007, 28:108-114.
12. DeKoter R.P., Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 2000, 288:1439-1441.
13. DeKoter R.P., Lee H.J., Singh H. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 2002, 16:297-309.
14. Guerriero A., Langmuir P.B., Spain L.M., Scott E.W. PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells. Blood 2000, 95:879-885.
15. Hayashi S., McMahon A.P. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev. Biol. 2002, 244:305-318.
16. Hohaus S., Petrovick M.S., Voso M.T., Sun Z., Zhang D.E., Tenen D.G. PU.1 (Spi-1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene. Mol. Cell. Biol. 1995, 15:5830-5845.
17. Holmes M.L., Carotta S., Corcoran L.M., Nutt S.L. Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment. Genes Dev. 2006, 20:933-938.
18. Houston I.B., Kamath M.B., Schweitzer B.L., Chlon T.M., DeKoter R.P. Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality. Exp. Hematol. 2007, 35:1056-1068.
19. Huang S., Guo Y.P., May G., Enver T. Bifurcation dynamics in lineage-commitment in bipotent progenitor cells. Dev. Biol. 2007, 305:695-713.
20. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992, 176:1693-1702.
21. Iwasaki H., Somoza C., Shigematsu H., Duprez E.A., Iwasaki-Arai J., Mizuno S., Arinobu Y., Geary K., Zhang P., Dayaram T., et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 2005, 106:1590-1600.
22. Karsunky H., Merad M., Cozzio A., Weissman I.L., Manz M.G. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J. Exp. Med. 2003, 198:305-313.
23. Kingston D., Schmid M.A., Onai N., Obata-Onai A., Baumjohann D., Manz M.G. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood 2009, 114:835-843.
24. Laiosa C.V., Stadtfeld M., Xie H., de Andres-Aguayo L., Graf T. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors. Immunity 2006, 25:731-744.
25. Liu K., Victora G.D., Schwickert T.A., Guermonprez P., Meredith M.M., Yao K., Chu F.F., Randolph G.J., Rudensky A.Y., Nussenzweig M. In vivo analysis of dendritic cell development and homeostasis. Science 2009, 324:392-397.
26. Mackarehtschian K., Hardin J.D., Moore K.A., Boast S., Goff S.P., Lemischka I.R. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 1995, 3:147-161.
27. Manz M.G., Traver D., Miyamoto T., Weissman I.L., Akashi K. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 2001, 97:3333-3341.
28. Maraskovsky E., Brasel K., Teepe M., Roux E.R., Lyman S.D., Shortman K., McKenna H.J. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 1996, 184:1953-1962.
29. McKenna H.J., Stocking K.L., Miller R.E., Brasel K., De Smedt T., Maraskovsky E., Maliszewski C.R., Lynch D.H., Smith J., Pulendran B., et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000, 95:3489-3497.
30. McKercher S.R., Torbett B.E., Anderson K.L., Henkel G.W., Vestal D.J., Baribault H., Klemsz M., Feeney A.J., Wu G.E., Paige C.J., Maki R.A. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 1996, 15:5647-5658.
31. Merad M., Manz M.G. Dendritic cell homeostasis. Blood 2009, 113:3418-3427.
32. Naik S.H., Proietto A.I., Wilson N.S., Dakic A., Schnorrer P., Fuchsberger M., Lahoud M.H., O'Keeffe M., Shao Q.X., Chen W.F., et al. Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 2005, 174:6592-6597.
33. Naik S.H., Sathe P., Park H.Y., Metcalf D., Proietto A.I., Dakic A., Carotta S., O'Keeffe M., Bahlo M., Papenfuss A., et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat. Immunol. 2007, 8:1217-1226.
34. Nerlov C., Graf T. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 1998, 12:2403-2412.
35. Nutt S.L., Heavey B., Rolink A.G., Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999, 401:556-562.
36. Nutt S.L., Metcalf D., D'Amico A., Polli M., Wu L. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J. Exp. Med. 2005, 201:221-231.
37. Ogilvy S., Metcalf D., Print C.G., Bath M.L., Harris A.W., Adams J.M. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc. Natl. Acad. Sci. USA 1999, 96:14943-14948.
38. Onai N., Obata-Onai A., Tussiwand R., Lanzavecchia A., Manz M.G. Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development. J. Exp. Med. 2006, 203:227-238.
39. Onai N., Obata-Onai A., Schmid M.A., Ohteki T., Jarrossay D., Manz M.G. Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat. Immunol. 2007, 8:1207-1216.
40. Polli M., Dakic A., Light A., Wu L., Tarlinton D.M., Nutt S.L. The development of functional B lymphocytes in conditional PU.1 knock-out mice. Blood 2005, 106:2083-2090.
41. Rosenbauer F., Wagner K., Kutok J.L., Iwasaki H., Le Beau M.M., Okuno Y., Akashi K., Fiering S., Tenen D.G. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat. Genet. 2004, 36:624-630.
42. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994, 265:1573-1577.
43. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 2007, 7:19-30.
44. Sitnicka E., Bryder D., Theilgaard-Mönch K., Buza-Vidas N., Adolfsson J., Jacobsen S.E. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 2002, 17:463-472.
45. Sitnicka E., Buza-Vidas N., Ahlenius H., Cilio C.M., Gekas C., Nygren J.M., Månsson R., Cheng M., Jensen C.T., Svensson M., et al. Critical role of FLT3 ligand in IL-7 receptor independent T lymphopoiesis and regulation of lymphoid-primed multipotent progenitors. Blood 2007, 110:2955-2964.
46. Spooner C.J., Cheng J.X., Pujadas E., Laslo P., Singh H. A recurrent network involving the transcription factors PU.1 and Gfi1 orchestrates innate and adaptive immune cell fates. Immunity 2009, 31:576-586.
47. Tenen D.G., Hromas R., Licht J.D., Zhang D.E. Transcription factors, normal myeloid development, and leukemia. Blood 1997, 90:489-519.
48. Vremec D., Pooley J., Hochrein H., Wu L., Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 2000, 164:2978-2986.
49. Waskow C., Liu K., Darrasse-Jèze G., Guermonprez P., Ginhoux F., Merad M., Shengelia T., Yao K., Nussenzweig M. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 2008, 9:676-683.
50. Wu L., Liu Y.J. Development of dendritic-cell lineages. Immunity 2007, 26:741-750.
51. Wu L., D'Amico A., Hochrein H., O'Keeffe M., Shortman K., Lucas K. Development of thymic and splenic dendritic cell populations from different hemopoietic precursors. Blood 2001, 98:3376-3382.
52. Ye M., Ermakova O., Graf T. PU.1 is not strictly required for B cell development and its absence induces a B-2 to B-1 cell switch. J. Exp. Med. 2005, 202:1411-1422.
53. Yoshida T., Ng S.Y., Zuniga-Pflucker J.C., Georgopoulos K. Early hematopoietic lineage restrictions directed by Ikaros. Nat. Immunol. 2006, 7:382-391.